Current status and future perspectives in gastric cancer management

Cancer Treatment Reviews

Volumn 26, Issue 4, 2000, Pages 243-255

  Roukos, Dimitrios H ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; IRINOTECAN;

CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; ENDOSCOPIC SURGERY; GASTRECTOMY; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PROGNOSIS; REVIEW; STOMACH CANCER; SURVIVAL TIME;

EID: 0034254165     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0164     Document Type: Review

References (130)

1. Whelan, S. L.Parkin, D. M.Masuyer, E. Trends in Cancer Incidence and Mortality. Lyon, France, IARC Scientific Publications, 1993.
2. Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F. Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287-1289.
3. Craanen M. E., Dekker W., Blok P., Ferwerda J., Tytgat G. N. Time trends in gastric carcinoma: changing pattern type and location. Am J Gastroenterol. 87:1992;572-579.
4. Fuchs C. S., Mayer R. J. Gastric carcinoma. New Engl J Med. 333:1995;32-41.
5. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52:1992;6735-6740.
6. Tahara E. Molecular biology of gastric cancer. World J Surg. 19:1995;484-490.
7. Miller A. B., Berrinto F., Hill M., Pietinen P., Riboli E., Wahrendorf J. Diet in the etiology of cancer: a review. Eur J Cancer. 30:1994;207-220.
8. Tsugane S., Tei Y., Takahashi T., Watanabe S., Sugano K. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res. 85:1994;474-478.
9. Wu Y., Chen J. The preventive role of diet in stomach cancer. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;57-63 Monduzzi Editore, Bologna (Italy).
10. Kitahara F., Shimazaki R., Kojima Y., Morozumi A., Fujino M. A. Severe atrophic gastritis with Helicobacter pylori infection and gastric cancer. Gastric Cancer. 1:1998;118-124.
11. Hiki Y. Endoscopic treatment for gastric cancer from the surgical perspective. Gastroenterol Endosc. 5:1991;141.
12. Jentschura D., Heubner C., Manegold B. C., Rumstadt B., Winkler M., Trede M. Surgery for early gastric cancer: a european one-center experience. World J Surg. 21:1997;845-849.
13. Sano T., Sasako M., Kinoshita T., Marujama K. Recurrence of early gastric cancer: follow-up of 1475 patients and review of the Japanese literature. Cancer. 72:1993;3174-3178.
14. Iriyama K., Asakawa T., Koike H., Nishiwaki H., Suzuki H. Extensive lymphadenectomy necessary for surgical treatment for intramucosal carcinoma of the stomach? Arch Surg. 124:1989;309-311.
15. Baba H., Maehara Y., Takeuchi H. Effect of lymph node dissection on the prognosis in patients with node - negative early gastric cancer. Surgery. 117:1995;165-169.
16. Tsujitani S., Oka S., Saito H., Kondo A., Masahide I., Maeta M., Kaibara N. Less invasive surgery for early gastric cancer based on the low probability of lymph node metastasis. Surgery. 125:1999;148-154.
17. Folli S., Dente M., Dell'amore D., Nanni O., Saragoni L., Vio A. Early gastric cancer: prognostic factors in 223 patients. Br J Surg. 62:1995;952-956.
18. Sasako M., McCulloch P., Kinoshita T., Marujama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 82:1995;346-351.
19. Park C. H., Park S. M., Kim I. C. Treatment strategies for early gastric cancer. Siewert J. R., Roder J. D. Proceedings of the 2nd International Gastric Cancer Congress, Munich. 1997;841-844.
20. Nagashima T., Ueno I., Kobayashi N. Endoscopic mucosal resection for early gastric cancer. Siewert J. R., Roder J. D. Proceedings of the 2nd International Gastric Cancer Congress, Munich. 1997;845-848.
21. Kitamura K., Yamaguchi T., Taniguchi H., Hagiwara A., Sawai K., Takahashi T. Analysis of lymph node metastasis in early gastric cancer: rationale of limited surgery. J Surg Oncol. 64:1997;42-47.
22. Hanazaki K., Wakabayashi M., Sodeyama W. Surgical outcome in early gastric cancer with lymph node metastasis. Hepatogastroenter. 44:1997;907-911.
23. Seto Y., Nagawa H., Muto Y. Impact of lymph node metastasis on survival with early gastric cancer. World J Surg. 1997;186-189.
24. Sano T., Kibori O., Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg. 79:1992;241-244.
25. Hiki Y., Shimao H., Mieno H., Sakakibara Y., Kobayashi N., Saigenji K. Modified treatment of early gastric cancer: evaluation of endoscopic treatment of early gastric cancers with respect to treatment indications groups. World J Surg. 19:1995;517-522.
26. Ohgami M., Otani Y., Kumai K., Kubota T., Kim Y., Kitajima M. Curative laparoscopic surgery for early gastric cancer: Five years experience. World J Surg. 23:1999;187-193.
27. Ohashi S., Taniguchi E., Takikiguchi S. Laparoscopic intra-gastric surgery (LIGS) for early gastric cancer: a laparoscopic endo-organ surgery. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;117-119 Monduzzi Editore, Bologna (Italy).
28. Murata Y., Suzuki S., Oguma H., Mitsunagna A., Kitamura Y., Takasaki T. Recent progress in staging gastric cancer by endoscopic ultrasonography. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;109-114 Monduzzi Editore, Bologna (Italy).
29. Shim, C. S. Endoscopic mucosal resection. 3rd International Gastric Cancer Congress, 27-30 April 1999, Seoul, Abstracts, 49.
30. Feussner, H. Minimally invasive treatment for early gastric cancer: Laparoscopic or minimally invasive surgery. 3rd International Gastric Cancer Congress, 27-30 April 1999, Seoul, Abstracts, 52.
31. Yanai H., Tada M., Karita M,Okita K. Daignostic utility of 20-megahertz linear endoscopic ultrasonography in early gastric cancer. Gastrointest Endosc. 44:1996;29-33.
32. Akahoshi K., Chijiwa Y., Sasaki I. Pre-operative TN staging of gastric cancer using a 15 MHZ ultrasound miniprobe. Br J Radiol. 70:1997;703-707.
33. Siewert J. R., Kestlmeier R., Busch R., Boettcher K., Roder J. D., Mueller J. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg. 83:1996;1144-1147.
34. Roukos D. H. Extended lymphadenectomy in gastric cancer: When, for whom and why. Ann Roy Coll Surg Engl. 80:1998;16-24.
35. Zhang D., Shimoyama S., Kaminishi M. Feasibility of pylorus-preserving gastrectomy with a wider scope of lymphadenectomy. Arch Surg. 133:1998;993-997.
36. Furukawa H., Hiratsuka M., Imaoka S. Limited surgery for early gastric cancer in cardia. Ann Surg Oncol. 5:1998;338-341.
37. Ti T. K. Function preserving gastric resection. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;121-125 Monduzzi Editore, Bologna (Italy).
38. Wanebo H. J., Kennedy B. J., Chmiel J., Steele G., Winchester D., Osteen R. Cancer of the stomach: a patient care study by the American College of Surgerons. Ann Surg. 218:1993;583-587.
39. Gouzi J. L., Huguier M., Fagniez P. L. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A Frence prospective controlled study. Ann Surg. 209:1989;162-166.
40. Siewert J. R., Boettcher K., Stein H. J. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg. 228:1998;449-461.
41. Degiuli M., Allone T., Danese F., Cassini P., Soldati T., Calvo F. Cancer treatment on gastric cancer: Italian quidelines for the diagnosis and treatment of gastric cancer in Italy. Results of a national inquire on gastruc cancer treatment. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;17-22 Monduzzi Editore, Bologna (Italy).
42. Marujama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 11:1987;418-425.
43. Okajima K., Isozaki H. Splenectomy for treatment of gastric cancer: Japanese experience. World J Surg. 19:1995;537-540.
44. Roukos D., Hottenrott C., Lorenz M., Encke A. Stadien- und Lokalisationsgerechte Chirurgie zur Milzerhaltung beim Magenkarzinom. Akt Chir. 24:1989;96-101.
45. Sano T., Kobori O., Nagawa H., Muto T. The macroscopic diagnosis of lymph node metastasis from early gastric cancer. Surgery Today. 24:1994;37-39.
46. Robertson C. S., Chung S. C. S., Woods S. D. S. A prospective randomised trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg. 220:1994;176-182.
47. Roukos D., Schmidt-Mathiesen A., Encke A. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Surg Oncol. 4:1995;323-364.
48. Brady M. S., Rogatho A., Dent L. L., Shiou M. H. Effect of splenectomy on morbidity and survival following curative gastrectomy for gastric carcinoma. Arch Surg. 26:1991;359-364.
49. Adachi Y., Kamakura T., Mori M., Maechara Y., Sugimachi K. Role of lymph node dissection and splenectomy in node positive gastric carcinoma. Surgery. 116:1994;837-841.
50. Griffith J. P., Sue-Ling H. M., Dixon M. F., McMahon M. J., Axon A. T. R., Johnston D. Preservation of spleen improves survival after radical surgery for gastric cancer. Gut. 36:1995;684-690.
51. Otsuji E., Yamaguchi T., Sawai K., Ohara M., Takahashi T. End results of simultaneus splenectomy in patients undergoing total gastrectomy for gastric carcinoma. Surgery. 120:1996;40-44.
52. Cuschieri A., Fayers P., Fielding J. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 347:1996;995-999.
53. Bonnenkamp J. J., Hermans J., Sasako M., van de Velde C. J. H. Extended lymph-node dissection for gastric cancer. N Engl J Med. 340:1999;908-914.
54. Wanebo H. J., Kennedy B. J., Winchester D. P., Stewart A., Fremgen M. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg. 185:1997;177-184.
55. Stipa S., DiGiorgio A., Ferri M., Botti C. Results of curative gastrectomy for carcinoma. J Am Coll Surg. 17:1994;567-572.
56. Kwon S. J. Prognostic impact of splenectomy on gastric cancer: results of the Korean gastric cancer study group. World J Surg. 21:1997;837-844.
57. Marujama K., Sasako M., Kinoshita T., Sano T., Katai H., Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg. 19:1995;532-536.
58. Hermanek P., Sobin L. H. TNM Classification of Malignant Tumours. International Union Against Cancer, (UICC), 4th edn. 1992;Berlin, Springer
59. Bearhs O. H., Henson D. E., Hutter R. V. P., Kennedy B. J. Manual for Staging. American Joint Committee on Cancer, 4th edn. 1992;J. B Lippincott, Philadelphia.
60. Nishi M., Omori Y., Miwa K. Japanese Classification of Gastric Carcinoma. Japanese Research Society for Gastric Cancer (JRSGC), 1st English edn. 1995;Kanehara & Co. Tokyo.
61. Okusa T., Nakane Y., Boku T. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet. 170:1990;488-494.
62. Isozaki H., Okajima K., Kawashima Y. Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol. 53:1993;247-251.
63. Makino M., Moriwaki S., Yonekawa M., Oota M., Kaibara N. Prognostic significance of the number of metastatic lymph nodes in patients with gastric cancer. J Surg Oncol. 47:1991;12-16.
64. Wu C. W., Hsieh M. C., Lo S. S., Tsay S. H., Lui W. Y., Peng F. K. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut. 38:1996;525-527.
65. Sobin L. H., Wittekind C. H. TNM classification of malignant yumours. International Union Against Cancer (UICC), 5th edn. 1997;John Wiley & Sons, New York.
66. Roder J. D., Boettcher K., Busch R., Wittekind C., Hermanek P., Siewert J. R. Classification of regional lymph node metastasis from gastric carcinoma. Cancer. 82:1998;621-631.
67. Kodera Y., Yamamura Y., Shimizu Y. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg. 187:1998;597-603.
68. Okamoto K., Swai K., Minato H. Number and anatomical extent of lymph node metastases in gastric cancer: analysis using intra-lymph node injection of activated carbon particles. Jpn J Clin Oncol. 29:1999;74-77.
69. Yoo C. H., Noh S. H., Kim Y., Min J. S. Comparison of prognostic significance of nodal staging between old (4th edn) and new (5th edn) UICC TNM classification for gastric cancer. World J Surg. 23:1999;492-498.
70. Kodama Y., Sugimachi K., Soejima K., Matusaka T., Inokuchi K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg. 5:1981;241-248.
71. Pacelli F., Doglieto G. B., Bellantone R., Alfieri S., Sgadari A., Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg. 80:1993;1153-1156.
72. Shiu M. H., Moore E., Sanders M., Huvos A., Freedman B., Goodbold J. Influence of the extent of resection on survival after curative treatment of gastric carcinoma. Arch Surg. 122:1987;1347-1351.
73. Jaehne J., Meyer H. J., Maschek H., Geerlings H., Bruns E., Pichlmayr R. Lymphadenectomy in gastric carcinoma. Arch Surg. 127:1992;290-294.
74. Boettcher K., Becker K., Busch R., Roder J. D., Siewert J. R. Prognosefaktoren beim Magen-karzinom: Ergebnisse einer uni- und multivariaten Analyse. Chirurg. 63:1992;656-661.
75. Roukos D., Hottenrott C., Lorenz M., Koutsogiorgas-Couchell S. A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach. J Cancer Res Clin Oncol. 116:1990;307-313.
76. Soreide J. A., van-Heerden J. A., Burger L. J., Donohue J. H., Sarr M. G., Ilstrup D. M. Surgical aspects of patients with adenocarcinoma operated on for cure. Arch Surg. 131:1996;481-486.
77. Wanebo H. J., Kennedy B. J., Winchester D. P., Fremgen A., Stewart A. K. Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg. 183:1996;616-624.
78. Brennan M. F. Lymph-node dissection for gastric cancer. New Engl J Med. 340:1999;956-958.
79. Smith J. W., Shiou M. H., Kelsey L., Brennan M. F. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg. 126:1991;1469-1473.
80. Sue-Ling H. M., Johnston D., Martin I. G., Dison M. F. Gastric cancer: a curable disease in Britain. BMJ. 307:1993;591-596.
81. Maruyama, K. Kaminishi, N. Committee of Nation-wide Registry, Japanese Gastric Cancer Association, Japanese experience: from data of nation-wide registry. 3rd International Gastric Cancer Congress, April 27-30, 1999, Seoul (Korea), Abstracts, 82.
82. Roukos D. H., Lorenz M., Encke A. Evidence of survival benefit of extended lymphadenectomy in Western gastric cancer patients based on a new concept. A prospective long-term follow-up study. Surgery. 123:1998;573-578.
83. Degiuli M., Sasako M., Soldati T. Results of the Italian Gastric Cancer Study Group prospective multi-center surgical trial on D2-gastrectomy for gastric cancer. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;155-161 Monduzzi Editore, Bologna (Italy).
84. Bunt A. M.G., Hermans J., Smit V. T. H. B. M., van de Velde C. J. H., Fleuren G. J., Bruijn J. A. Surgical/pathologic-stage migration confounds comparison of gastric cancer survival rates between Japan and Western contries. J Clin Oncol. 13:1995;19-25.
85. Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 312:1985;1604-1608.
86. Roukos, D. H. Extended lymph-node dissection in gastric cancer: Standard, selective or unnecessary procedure?, Hepatogastroenterology.
87. Bonnenkamp J. J., Hermans J., Sasako M., Van de Velde C. J. H. Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer. Gastric Cancer. 1:1998;152-159.
88. Roukos D. H. Therapeutic value of D2-resection in gastric cancer evaluated with a new concept. UICC Concensus Conference. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;29-33 Monduzzi Editore, Bologna (Italy).
89. Katai H., Marujam K., Sasako M., Sano T. Incidence of nodal metastasis around the superior border of the pancreas based on number of metastatic perigastric nodes. Gastric Cancer. 1:1998;115-117.
90. Sackett D. L., Rosenberg W. M. C., Gray J. A. M., Haynes R. B., Richardson W. S. Evidence based medicine: what it is and what it isn't. BMJ. 312:1996;71-72.
91. Black N. Evidence-based surgery: a passing fad? World J Surg. 23:1999;789-793.
92. Solomon M. J., McLeod R. S. Should we be performing more randomized controlled trials evaluating surgical operations? Surgery. 118:1995;459-467.
93. Troidl H. First step: the idea. World J Surg. 23:1999;754-767.
94. Pollock A. V. The rise and fall of the random controlled trial in surgery. Theor Surg. 4:1989;163.
95. Ellis J., Mulligan I., Rowe J., Sackert D. L. Inpatient general medicine is evidence based; A team Nuffield Department of Clinical Medicine. Lancet. 346:1995;497.
96. Kaibara N., Sumi K., Yonekawa M. Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer? Am J Surg. 159:1990;218-221.
97. Korenaga D., Moriguchi S., Orita H. Trends in survival rates in Japanese patients with advanced carcinoma of the stomach. Surg Gynecol Obstet. 174:1992;387-393.
98. Hallissey M. T., Dunn JAWard L. C. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet. 343:1994;1309-1312.
99. Kim J. P., Kwon O. J., Oh S. T., Yang H. K. Result of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg. 216:1992;269-279.
100. Nakazato H., Koike A., Saji S., Ogawa N., Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet. 343:1994;1122-1126.
101. Gunduz N., Fisher B., Saffer E. A. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res. 39:1979;3861-3865.
102. Fisher B., Gunduz N., Saffer E. A. Influence of the interval between primary tumor removal and chemotherapy in kinetics and growth of metastases. Cancer Res. 43:1983;1488-1492.
103. Hermans J., Bonenkamp J. J., Boon M. C. Adjuvant therapy after curative resection for gastric cancer: metaanalysis of randomised trials. J Clin Oncol. 11:1993;1441-1447.
104. Averbach A. M., Jacquet P. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg. 83:1996;726-733.
105. Kim J. P. Surgical results with immunochemotherapy. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;3-9 Monduzzi Editore, Bologna (Italy).
106. Meyer H. J., Wilke H. Gastric carcinoma: how to prevent recurrence. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;171-175 Monduzzi Editore, Bologna (Italy).
107. Fink U., Schumacher C., Stein H. J. Preoperative chemotherapy for stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection. Br J Surg. 82:1995;1248-1252.
108. Grundei T., Fink U., Matzen K. Neoadjuvant chemotherapy with Cisplatin, Leucovorin and 5 Fluorouracil (PLF) for locally advanced gastric cancer. Siewert J. R., Roder J. D. Proceedings of the 2nd International Gastric Cancer Congress, Munich 1997. 1997;1323-1326 Monduzzi Editore, Bologna (Italy).
109. Siewert, J. R. Neoadjuvant treatment in gastric cancer. 3rd International Gastric Cancer Congress, April 27-30, 1999, Seoul (Korea), Abstracts, 53.
110. Kang Y. K., Choi D. W., Im Y. H. A phase III randomised comparison of neoadjuvant chemotherapy followed by surgery for locally advanced stomach cancer. Proc Am Soc Clin Oncol. 15:1996;215.
111. Yonemura Y., Sawa T., Kinoshita K. Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg. 17:1993;256-262.
112. Van de Velde, C. J. H. for the Dutch Gastric Cancer Group, Surgery and chemotherapy for operable gastric cancer results of two randomized trials. 3rd International Gastric Cancer Congress, Seoul 1999, Abstracts, 85.
113. Iitsuka Y., Kaneshima S., Taneda O., Takeuchi T., Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer. 44:1979;1476-1480.
114. Hansen E., Wolff N., Kneuchel R., Ruschoff J., Hofstaedter F., Taeger K. Tumour cells in blood shed from the surgical field. Arch Surg. 130:1995;387-393.
115. Koga S., kaibara N., Iitsuka Y., Kudo H., Kimura A., Horaoka H. Prognostic significance of itraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol. 1984;236-238.
116. Baba H., Korenaga D., Haraguchi M. Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion. Cancer. 64:1989;2482-2486.
117. Haraguchi M., Watanabe A., Kakeji Y. Prognostic significance of serosal invasion in carcinoma of the stomach. Surg Gynecol Obstet. 172:1991;29-32.
118. Meyer H. J., Opitz G. J., Jaehne J. Hypothetisches und Gesichertes zur prae-, intra- und postoperativen Zusatztherapie des Magencarcinoms. Langenbecks Arch Chir. Suppl II:1998;312-317.
119. Elias D., Detroz B., Debaine B. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: Reliab le and unreliable concepts. Hepatogastroenterology. 41:1994;207-213.
120. Hama Z. R., Maeta M., Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer. 73:1994;2048-2052.
121. Yonemura Y., Ninomija I., Kaji M. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg. 19:1995;450-455.
122. Sik, M. J. Results of surgical treatment for gastric cancer in Korea. 3rd International Gastric Cancer Congress, Seoul 1999, Abstract, 83.
123. Kim S. M., Um J. W., Mok Y. J., Kim S. J., Kim J. S. Management of postoperative recurrence. Present, future. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;165-170 Monduzzi Editore, Bologna (Italy).
124. Takahashi T., Hagiwara A., Shimotsuma M., Sawai K., Yamaguchi T. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J Surg. 19:1995;565-569.
125. Sugarbaker P. H., Averabach A. M., Chang D. Adjuvant perioperative intraoperitoneal chemotherapy for resectable gastric cancer. Siewert J. R., Roder J. D. Proceedings of the 2nd International Gastric Cancer Congress, Munich: 1997. 1997;1399-1405 Monduzzi Editore, Bologna (Italy).
126. Rosen H. R., Jatzko G., Repse S. T. Adjuvant intraperitoneal chemotherapy with carbon-absorbed mitomycin in patients with gastric cance: Results of a multicenter trial of the Austrian working group for surgical oncology. J Clin Oncol. 16:1998;2733-2738.
127. Crookes P., Leichman C. G., Leichman L. Systematic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy. Cancer. 79:1997;1767-1775.
128. Budach V. G. F. The role of radiatio therapy in the management of gastric cancer. Ann Oncol. 5:1994;37-48.
129. Farthmann E. H., Frommhold H., Wagner C., Henne K., Ruf G. Locally advanced gastric cancer: surgical aspects of radiation therapy. Kim J. P., Min J. S., Mok Y. J. Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. 1999;143-147 Monduzzi Editore, Bologna (Italy).
130. Akoh J. A., MacIntyre I. M. C. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg. 79:1992;293-299.